I have lowered my intake some, not a lot, and am still tettering between the two numbers I was already weighing
As Tirzepatide later demonstrated substantial weight-loss benefits in non-diabetic, overweight individuals (reinforced by both the SURPASS and SURMOUNT trials), Eli Lilly introduced Zepbound as a separate product approved specifically for weight loss and obesity-related conditions, including sleep apnea
Food and Drug Administration approved Zepbound, a tirzepatide medicine from Eli Lilly, for adults with obesity and moderate to severe obstructive sleep apnea, alongside a reduced-calorie diet and more physical activity
Appetite returning during maintenance is normal, not failure
Always check the expiration date before use, and inspect the medication for any changes in color or particles before injection